These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 7075441)

  • 21. Radionuclide bone scanning of medullary chondrosarcoma.
    Hudson TM; Chew FS; Manaster BJ
    AJR Am J Roentgenol; 1982 Dec; 139(6):1071-6. PubMed ID: 6216791
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Value of pre-treatment and follow-up skeletal scintigraphy in operable breast cancer.
    Pauwels EK; Heslinga JM; Zwaveling A
    Clin Oncol; 1982 Mar; 8(1):25-32. PubMed ID: 6280915
    [No Abstract]   [Full Text] [Related]  

  • 23. Is bone scanning of value in patients with breast cancer?
    Spencer GR; Khan M; Bird C; Seymour R; Brown TR; Collins CD
    Acta Chir Scand; 1981; 147(4):247-8. PubMed ID: 6459704
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Skeletal metastases of melanoma: radiographic, scintigraphic, and clinical review.
    Fon GT; Wong WS; Gold RH; Kaiser LR
    AJR Am J Roentgenol; 1981 Jul; 137(1):103-8. PubMed ID: 6787858
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Scintigraphic evaluation of giant cell tumor of bone.
    Levine E; De Smet AA; Neff JR; Martin NL
    AJR Am J Roentgenol; 1984 Aug; 143(2):343-8. PubMed ID: 6234786
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radiographic and scintigraphic skeletal imaging in patients with neuroblastoma: concise communication.
    Baker M; Siddiqui AR; Provisor A; Cohen MD
    J Nucl Med; 1983 Jun; 24(6):467-9. PubMed ID: 6854397
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparison of skeletal uptakes of three diphosphonates by whole-body retention: concise communication.
    Fogelman I; Pearson DW; Bessent RG; Tofe AJ; Francis MD
    J Nucl Med; 1981 Oct; 22(10):880-3. PubMed ID: 6457135
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of lung metastases from osteosarcoma by scintigraphy using 99mTc-methylene diphosphonate.
    Hoefnagel CA; Bruning PF; Cohen P; Marcuse HR; van der Schoot JB
    Diagn Imaging; 1981; 50(5):277-84. PubMed ID: 6457735
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radionuclide liver and bone scanning in the evaluation of patients with endometrial carcinoma.
    Mettler FA; Christie JH; Garcia JF; Baldwin MH; Wicks JD; Bartow SA
    Radiology; 1981 Dec; 141(3):777-80. PubMed ID: 6272356
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A radiopharmaceutical and clinical comparison of 99mTc-Sn-hydroxymethylene diphosphonate with 99mTc-Sn-hydroxyethylidene diphosphonate.
    Silberstein EB
    Radiology; 1980 Sep; 136(3):747-51. PubMed ID: 6773104
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of ureteral obstruction on radionuclide bone scans.
    Pollen JJ; Gerber K; Heil BJ; Talner LB
    AJR Am J Roentgenol; 1983 Sep; 141(3):567-70. PubMed ID: 6224403
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Whole body retention of diphosphonate in rheumatoid arthritis.
    Steven MM; Sturrock RD; Fogelman I; Smith ML
    J Rheumatol; 1982; 9(6):873-7. PubMed ID: 7161778
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The flare phenomenon on radionuclide bone scan in metastatic prostate cancer.
    Pollen JJ; Witztum KF; Ashburn WL
    AJR Am J Roentgenol; 1984 Apr; 142(4):773-6. PubMed ID: 6230903
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Value of skeletal scintigraphy in the therapy of breast cancer].
    Köhler AH; Weidig W
    Zentralbl Chir; 1982; 107(22):1433-9. PubMed ID: 7164627
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relative lesion detection ability of Tc-99m HMDP and Tc-99m MDP: concise communication.
    Van Duzee BF; Schaefer JA; Ball JD; Chilton HM; Cowan RJ; Kuni C; Trow R; Watson NE
    J Nucl Med; 1984 Feb; 25(2):166-9. PubMed ID: 6233404
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative evaluation of 99mTc-pertechnetate, 99mTc-diphosphonate, 99mTc-Solcocitran, 99mTc-iron-ascorbic acid and 67Ga-citrate as brain scanning agents.
    Pétursson E; Björnsson OG; Björnsson OJ; Davídsson D
    Nuklearmedizin; 1982 Dec; 21(6):265-73. PubMed ID: 6300799
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Quantitative whole-body bone scintigraphy. III. Clinical significance for the diagnosis of bone metastases, systemic bone diseases and diseases of the joint (author's transl)].
    Anger K; Küper K
    Nuklearmedizin; 1980 Jul; 19(3):108-19. PubMed ID: 7465430
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Utility of bone scanning in detecting occult skeletal metastases from cervical carcinoma.
    Katz RD; Alderson PO; Rosenshein NB; Bowerman JW; Wagner HN
    Radiology; 1979 Nov; 133(2):469-72. PubMed ID: 493539
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanism of uptake of bone imaging isotopes by skeletal metastases.
    Galasko CS
    Clin Nucl Med; 1980 Dec; 5(12):565-8. PubMed ID: 6254718
    [No Abstract]   [Full Text] [Related]  

  • 40. A computer assisted comparison of 99Tcm-methylene-diphosphonate and 99Tcm-pyrophosphate bone imaging.
    Büll U; Pfeifer JP; Niendorf HP; Tongendorff J
    Br J Radiol; 1977 Sep; 50(597):629-36. PubMed ID: 198055
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.